Aims Cardiac resynchronization therapy (CRT) plays a pivotal role in the management of
patients with heart failure (HF) and wide QRS complex. However, the treatment is plagued …

Ventricular arrhythmias associated with mitral valve prolapse (MVP) and the capacity to
cause sudden cardiac death (SCD), referred to as 'malignant MVP', are an increasingly …

Over the past two decades of CRT use, the failure rate has remained around 30–35%,
despite several updates in the guidelines based on the understanding from multiple trials …

Aims Cardiac resynchronization therapy (CRT) restores mechanical efficiency to the failing
left ventricular (LV) by resynchronization of contraction. Global, LV myocardial work …

Background—Response to cardiac resynchronization therapy is most favorable in patients
with heart failure with QRS duration≥ 150 ms and left bundle branch block and less …

Background Long-term RVP could bring adverse problems to cardiac electro-mechanics
and result in inter-and intra-ventricular asynchrony, impaired labor force, and aggravation of …

Figura Central: Posicionamento do Departamento de Imagem Cardiovascular da Sociedade
Brasileira de Cardiologia sobre o Uso do Strain Miocárdico na Rotina do Cardiologista …

Background: Cross correlation analysis (CCA) using tissue Doppler imaging has been
shown to be associated with outcome after cardiac resynchronization therapy (CRT) in …

Cardiac resynchronization therapy (CRT) is an established nonpharmacological treatment
for patients with heart failure (HF), reduced left ventricular (LV) ejection fraction, and a wide …

The role of electromechanical dyssynchrony in heart failure gained prominence in literature
with the results of trials of cardiac resynchronization therapy (CRT). CRT has shown to …